Uterine leiomyomas: MR imaging- based thermometry and thermal dosimetry during focused ultrasound thermal ablation

Nathan McDannold, Clare M. Tempany, Fiona M. Fennessy, Minna J. So, Frank J. Rybicki, Elizabeth A Stewart, Ferenc A. Jolesz, Kullervo Hynynen

Research output: Contribution to journalArticle

165 Citations (Scopus)

Abstract

Purpose: To retrospectively evaluate magnetic resonance (MR) imaging-based thermometry and thermal dosimetry during focused ultrasound treatments of uterine leiomyomas (ie, fibroids). Materials and Methods: All patients gave written informed consent for the focused ultrasound treatments and the current HIPAA-compliant retrospective study, both of which were institutional review board approved. Thermometry performed during the treatments of 64 fibroids in 50 women (mean age, 46.6 years ± 4.5 [standard deviation]) was used to create thermal dose maps. The areas that reached dose values of 240 and 18 equivalent minutes at 43°C were compared with the nonperfused regions measured on contrast material-enhanced MR images by using the Bland-Altman method. Volume changes in treated fibroids after 6 months were compared with volume changes in nontreated fibroids and with MR-based thermal dose estimates. Results: While the thermal dose estimates were shown to have a clear relationship with resulting nonperfused regions, the nonperfused areas were, on average, larger than the dose estimates (means of 1.9 ± 0.7 and 1.2 ± 0.4 times as large for areas that reached 240- and 18-minute threshold dose values, respectively). Good correlation was observed for smaller treatment volumes at the lower dose threshold (mean ratio, 1.0 ± 0.3), but for larger treatment volumes, the nonperfused region extended to locations within the fibroid that clearly were not heated. Variations in peak temperature increase were as large as a factor of two, both between patients and within individual treatments. On average, the fibroid volume reduction at 6 months increased as the ablated volume estimated by using the thermal dose increased. Conclusion: Study results showed good correlation between thermal dose estimates and resulting nonperfused areas for smaller ablated volumes. For larger treatment volumes, nonperfused areas could extend within the fibroid to unheated areas.

Original languageEnglish (US)
Pages (from-to)263-272
Number of pages10
JournalRadiology
Volume240
Issue number1
DOIs
StatePublished - Jul 2006
Externally publishedYes

Fingerprint

Thermometry
Leiomyoma
Hot Temperature
Magnetic Resonance Imaging
Therapeutics
Magnetic Resonance Spectroscopy
Health Insurance Portability and Accountability Act
Research Ethics Committees
Informed Consent
Contrast Media
Retrospective Studies
Temperature

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

McDannold, N., Tempany, C. M., Fennessy, F. M., So, M. J., Rybicki, F. J., Stewart, E. A., ... Hynynen, K. (2006). Uterine leiomyomas: MR imaging- based thermometry and thermal dosimetry during focused ultrasound thermal ablation. Radiology, 240(1), 263-272. https://doi.org/10.1148/radiol.2401050717

Uterine leiomyomas : MR imaging- based thermometry and thermal dosimetry during focused ultrasound thermal ablation. / McDannold, Nathan; Tempany, Clare M.; Fennessy, Fiona M.; So, Minna J.; Rybicki, Frank J.; Stewart, Elizabeth A; Jolesz, Ferenc A.; Hynynen, Kullervo.

In: Radiology, Vol. 240, No. 1, 07.2006, p. 263-272.

Research output: Contribution to journalArticle

McDannold, N, Tempany, CM, Fennessy, FM, So, MJ, Rybicki, FJ, Stewart, EA, Jolesz, FA & Hynynen, K 2006, 'Uterine leiomyomas: MR imaging- based thermometry and thermal dosimetry during focused ultrasound thermal ablation', Radiology, vol. 240, no. 1, pp. 263-272. https://doi.org/10.1148/radiol.2401050717
McDannold, Nathan ; Tempany, Clare M. ; Fennessy, Fiona M. ; So, Minna J. ; Rybicki, Frank J. ; Stewart, Elizabeth A ; Jolesz, Ferenc A. ; Hynynen, Kullervo. / Uterine leiomyomas : MR imaging- based thermometry and thermal dosimetry during focused ultrasound thermal ablation. In: Radiology. 2006 ; Vol. 240, No. 1. pp. 263-272.
@article{3fd7f4b73659412686df551b07cd42aa,
title = "Uterine leiomyomas: MR imaging- based thermometry and thermal dosimetry during focused ultrasound thermal ablation",
abstract = "Purpose: To retrospectively evaluate magnetic resonance (MR) imaging-based thermometry and thermal dosimetry during focused ultrasound treatments of uterine leiomyomas (ie, fibroids). Materials and Methods: All patients gave written informed consent for the focused ultrasound treatments and the current HIPAA-compliant retrospective study, both of which were institutional review board approved. Thermometry performed during the treatments of 64 fibroids in 50 women (mean age, 46.6 years ± 4.5 [standard deviation]) was used to create thermal dose maps. The areas that reached dose values of 240 and 18 equivalent minutes at 43°C were compared with the nonperfused regions measured on contrast material-enhanced MR images by using the Bland-Altman method. Volume changes in treated fibroids after 6 months were compared with volume changes in nontreated fibroids and with MR-based thermal dose estimates. Results: While the thermal dose estimates were shown to have a clear relationship with resulting nonperfused regions, the nonperfused areas were, on average, larger than the dose estimates (means of 1.9 ± 0.7 and 1.2 ± 0.4 times as large for areas that reached 240- and 18-minute threshold dose values, respectively). Good correlation was observed for smaller treatment volumes at the lower dose threshold (mean ratio, 1.0 ± 0.3), but for larger treatment volumes, the nonperfused region extended to locations within the fibroid that clearly were not heated. Variations in peak temperature increase were as large as a factor of two, both between patients and within individual treatments. On average, the fibroid volume reduction at 6 months increased as the ablated volume estimated by using the thermal dose increased. Conclusion: Study results showed good correlation between thermal dose estimates and resulting nonperfused areas for smaller ablated volumes. For larger treatment volumes, nonperfused areas could extend within the fibroid to unheated areas.",
author = "Nathan McDannold and Tempany, {Clare M.} and Fennessy, {Fiona M.} and So, {Minna J.} and Rybicki, {Frank J.} and Stewart, {Elizabeth A} and Jolesz, {Ferenc A.} and Kullervo Hynynen",
year = "2006",
month = "7",
doi = "10.1148/radiol.2401050717",
language = "English (US)",
volume = "240",
pages = "263--272",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "1",

}

TY - JOUR

T1 - Uterine leiomyomas

T2 - MR imaging- based thermometry and thermal dosimetry during focused ultrasound thermal ablation

AU - McDannold, Nathan

AU - Tempany, Clare M.

AU - Fennessy, Fiona M.

AU - So, Minna J.

AU - Rybicki, Frank J.

AU - Stewart, Elizabeth A

AU - Jolesz, Ferenc A.

AU - Hynynen, Kullervo

PY - 2006/7

Y1 - 2006/7

N2 - Purpose: To retrospectively evaluate magnetic resonance (MR) imaging-based thermometry and thermal dosimetry during focused ultrasound treatments of uterine leiomyomas (ie, fibroids). Materials and Methods: All patients gave written informed consent for the focused ultrasound treatments and the current HIPAA-compliant retrospective study, both of which were institutional review board approved. Thermometry performed during the treatments of 64 fibroids in 50 women (mean age, 46.6 years ± 4.5 [standard deviation]) was used to create thermal dose maps. The areas that reached dose values of 240 and 18 equivalent minutes at 43°C were compared with the nonperfused regions measured on contrast material-enhanced MR images by using the Bland-Altman method. Volume changes in treated fibroids after 6 months were compared with volume changes in nontreated fibroids and with MR-based thermal dose estimates. Results: While the thermal dose estimates were shown to have a clear relationship with resulting nonperfused regions, the nonperfused areas were, on average, larger than the dose estimates (means of 1.9 ± 0.7 and 1.2 ± 0.4 times as large for areas that reached 240- and 18-minute threshold dose values, respectively). Good correlation was observed for smaller treatment volumes at the lower dose threshold (mean ratio, 1.0 ± 0.3), but for larger treatment volumes, the nonperfused region extended to locations within the fibroid that clearly were not heated. Variations in peak temperature increase were as large as a factor of two, both between patients and within individual treatments. On average, the fibroid volume reduction at 6 months increased as the ablated volume estimated by using the thermal dose increased. Conclusion: Study results showed good correlation between thermal dose estimates and resulting nonperfused areas for smaller ablated volumes. For larger treatment volumes, nonperfused areas could extend within the fibroid to unheated areas.

AB - Purpose: To retrospectively evaluate magnetic resonance (MR) imaging-based thermometry and thermal dosimetry during focused ultrasound treatments of uterine leiomyomas (ie, fibroids). Materials and Methods: All patients gave written informed consent for the focused ultrasound treatments and the current HIPAA-compliant retrospective study, both of which were institutional review board approved. Thermometry performed during the treatments of 64 fibroids in 50 women (mean age, 46.6 years ± 4.5 [standard deviation]) was used to create thermal dose maps. The areas that reached dose values of 240 and 18 equivalent minutes at 43°C were compared with the nonperfused regions measured on contrast material-enhanced MR images by using the Bland-Altman method. Volume changes in treated fibroids after 6 months were compared with volume changes in nontreated fibroids and with MR-based thermal dose estimates. Results: While the thermal dose estimates were shown to have a clear relationship with resulting nonperfused regions, the nonperfused areas were, on average, larger than the dose estimates (means of 1.9 ± 0.7 and 1.2 ± 0.4 times as large for areas that reached 240- and 18-minute threshold dose values, respectively). Good correlation was observed for smaller treatment volumes at the lower dose threshold (mean ratio, 1.0 ± 0.3), but for larger treatment volumes, the nonperfused region extended to locations within the fibroid that clearly were not heated. Variations in peak temperature increase were as large as a factor of two, both between patients and within individual treatments. On average, the fibroid volume reduction at 6 months increased as the ablated volume estimated by using the thermal dose increased. Conclusion: Study results showed good correlation between thermal dose estimates and resulting nonperfused areas for smaller ablated volumes. For larger treatment volumes, nonperfused areas could extend within the fibroid to unheated areas.

UR - http://www.scopus.com/inward/record.url?scp=33745117579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745117579&partnerID=8YFLogxK

U2 - 10.1148/radiol.2401050717

DO - 10.1148/radiol.2401050717

M3 - Article

C2 - 16793983

AN - SCOPUS:33745117579

VL - 240

SP - 263

EP - 272

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 1

ER -